Post-Transfusion Acute Graft Versus Host Disease in a 17-Year-Old Girl with a Malignant Mesenchymal Tumor - Report of a Case

Acta Medica Austriaca

Volumn 30, Issue 5, 2003, Pages 138-141

  Utkan, G ^a   Buyukcelik, A ^a   Demir, O ^a   Sanli, H ^a   Pamir, A ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Post transfusion graft versus host disease; Rhabdomyosarcoma; Transfusion

Indexed keywords

ADOLESCENT; ARTICLE; AUTOPSY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CASE REPORT; FATALITY; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MESENCHYMOMA; SKIN;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; ERYTHROCYTE TRANSFUSION; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MESENCHYMOMA; RECURRENCE;

EID: 0346155814     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ali A, Blajchman M, Freedman J, Galligan B, Hannon J, Hébert M: Clinical guide to transfusion: Products and Practices. The Canadian Red Cross Society 1993.
2. Anderson K: Transfusion-associated graft-versus-host disease. J Clin Oncol 1991;9:1727-1730.
3. Anderson KC, Weinstein HJ: Transfusion-associated graft-versus-host disease. N Engl J Med 1990;323:315-321.
4. Antin JH, Ferrara JL: Cytokine dysregulation and acute graft-versus-host disease. Blood 1992;80:2964-2968.
5. Arat M, Aslan V, Arslan Ö, Kurt M, Gülbas Z: Transfusion associated graft-versus-host disease: 3 cases in Turkey. Vox Sang 2000;78[Suppl 1]:P642.
6. Arsura EL, Bertelle A, Minkowitz S, Cunningham JN Jr, Grob D: Transfusion-associated-graft-vs-host disease in a presumed immunocompetent patient. Arch Intern Med 1988;148:1941-1944.
7. Barrett AJ, Malkovska V: Graft-versus-leukaemia: understanding and using alloimmune response to treat haematological malignancies. Br J Haematol 1996; 93:754-761.
8. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R, et al: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610-630.
9. Devergie A, Janin A: Graft-versus-host disease. In: Apperley JF, Gluckman E, Gratwohl A, eds. Blood and Bone Marrow Transplantation. the EBMT handbook. Revised ed. 2000, pp 134-151.
10. Juji T, Nishimura M, Tadokoro K: Treatment of post transfusion graft-versus-host disease (Abstract). Vox Sang 2000;78 [Suppl 2]:277-279.
11. Juji T, Takahashi K, Shibata Y, Ide H, Sakakibara T, Ino T, Mori S: Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan. N Eng J Med 1989;321:356.
12. Kagi D, Vignaux B, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforine pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994;265:528-530.
13. Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K, et al: Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992;80:1838-1845.
14. Otsuka S, Kunieda K, Hirose M, Takeuchi H, Mizutani Y, Nagaya M, Sato G, Kasuya S, Matsutomo K, Noma A et al: Fatal erythroderma (suspected graft-versus-host disease) after cholecystectomy: Retrospective analysis. Transfusion 1989; 29:544-548.
15. Rappeport JM: Transfusion-associated graft-versus-host disease. Yale J Biol Med 1990;63:445-454.
16. Takahashi K, Juji T, Miyamoto M, Uchida S, Akaza T, Tadokoro K, Shibata Y, Ino T, Hidano A: Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group. Lancet 1994;343: 700-702.
17. Tasaki T, Ohto H, Abe R: Prevention of post-transfusion graft-versus-host disease (Abstract). Fukushima J Med Sci 1993;39:109-111.
18. Thaler M, Shamiss A, Orgad S, Huszar M, Nussinovitch N, Meisel S, Gazit E, Lavee J, Smolinsky A: The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med 1989;321:25-28.
19. Vogelsang GB: Transfusion-associated graft-versus-host disease disease in nonimmunocompromised host. Transfusion 1990;30:101-103.
20. Yasukawa M: Treatment of transfusion-associated graft-versus-host disease (abstract). Nippon Rinsho 1997;55:2290-2295.